Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000594184 | SCV000706186 | uncertain significance | not provided | 2017-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000594184 | SCV001824367 | uncertain significance | not provided | 2019-06-18 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); The majority of missense variants in this gene are considered pathogenic [(Stenson et al., 2014; other references)]; In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Revvity Omics, |
RCV000594184 | SCV003816976 | uncertain significance | not provided | 2019-12-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004586819 | SCV005077560 | uncertain significance | not specified | 2024-04-03 | criteria provided, single submitter | clinical testing | Variant summary: GNE c.1343C>T (p.Thr448Met) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. c.1343C>T has been reported in the literature in individuals affected with Thrombocytopaenia (Zieger_2022, Montcrieff_2022). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 36941763, 35052006). ClinVar contains an entry for this variant (Variation ID: 500300). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Natera, |
RCV001834895 | SCV002075652 | uncertain significance | GNE myopathy | 2020-07-28 | no assertion criteria provided | clinical testing |